{"database": "openregs", "table": "documents", "rows": [["EPA-HQ-OPP-2017-0489-0008", "EPA", "EPA-HQ-OPP-2017-0489", "24-Epibrassinolide: Summary of Hazard and Science Policy Council (HASPOC) Meeting on July 12, 2018: Recommendations on the need for waivers for the following subchronic studies: 90-Day Dermal Study (OSCPP 870.3250) and 90-Day Inhalation Study (OCSPP 870.3465)", "Supporting & Related Material", "Memorandum", "2019-06-19T04:00:00Z", 2019, 6, null, null, "2019-06-20T00:37:18Z", null, 0, 0, "0900006483ceec80"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["EPA-HQ-OPP-2017-0489-0008"], "units": {}, "query_ms": 0.3028159262612462, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}